Virpax Pharmaceuticals Inc (VRPX)
2.46
-0.08
(-3.15%)
USD |
NASDAQ |
May 02, 10:20
Virpax Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
Sorrento Therapeutics Inc | -0.6928 |
Scilex Holding Co | -0.7255 |
Coya Therapeutics Inc | 0.00 |
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | 0.00 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 9.628M |
Total Liabilities (Quarterly) | 7.694M |
Shareholders Equity (Quarterly) | 1.934M |